{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:11:39Z","timestamp":1744189899201,"version":"3.37.3"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Project for Prevention and Control of Transboundary Animal Diseases","award":["2017YFD0501804"],"award-info":[{"award-number":["2017YFD0501804"]}]},{"name":"National Key R&D Program for the 13th Five-Year Plan"},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key R&D Program","award":["2016YFC1202902"],"award-info":[{"award-number":["2016YFC1202902"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.intimp.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T19:15:35Z","timestamp":1536347735000},"page":"217-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Equine immunoglobulin F(ab\u2032)2 fragments protect mice from Rift Valley fever virus infection"],"prefix":"10.1016","volume":"64","author":[{"given":"Yongkun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuexing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihua","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuetao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Gai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hualei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feihu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiecheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0979-0526","authenticated-orcid":false,"given":"Songtao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangguo","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianzhu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2018.09.002_bb0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0924-8579(02)00295-9","article-title":"Rift Valley fever: an uninvited zoonosis in the Arabian peninsula","volume":"21","author":"Balkhy","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"5","key":"10.1016\/j.intimp.2018.09.002_bb0010","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/v3050493","article-title":"The pathogenesis of Rift Valley fever","volume":"3","author":"Ikegami","year":"2011","journal-title":"Viruses"},{"issue":"Suppl. 2","key":"10.1016\/j.intimp.2018.09.002_bb0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4269\/ajtmh.2010.09-0318","article-title":"Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007","volume":"83","author":"Mohamed","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"8","key":"10.1016\/j.intimp.2018.09.002_bb0020","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/378747","article-title":"Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics","volume":"37","author":"Madani","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2018.09.002_bb0025","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/0035-9203(79)90006-3","article-title":"Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness","volume":"73","author":"Laughlin","year":"1979","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.intimp.2018.09.002_bb0030","first-page":"65","article-title":"Rift valley fever","volume":"10","author":"Easterday","year":"1965","journal-title":"Adv. Vet. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2018.09.002_bb0035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11250-010-9719-7","article-title":"Risk assessment of the introduction of Rift Valley fever from the Horn of Africa to Yemen via legal trade of small ruminants","volume":"43","author":"Abdo-Salem","year":"2011","journal-title":"Trop. Anim. Health Prod."},{"issue":"3","key":"10.1016\/j.intimp.2018.09.002_bb0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.antiviral.2012.06.001","article-title":"Molecular biology and genetic diversity of Rift Valley fever virus","volume":"95","author":"Ikegami","year":"2012","journal-title":"Antivir. Res."},{"issue":"Pt 10","key":"10.1016\/j.intimp.2018.09.002_bb0045","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development","volume":"66","author":"Caplen","year":"1985","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.intimp.2018.09.002_bb0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated a virulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.intimp.2018.09.002_bb0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.antiviral.2014.03.008","article-title":"One Health approach to Rift Valley fever vaccine development","volume":"106","author":"Kortekaas","year":"2014","journal-title":"Antivir. Res."},{"issue":"17","key":"10.1016\/j.intimp.2018.09.002_bb0060","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1016\/j.vaccine.2011.02.037","article-title":"Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study","volume":"29","author":"Rusnak","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2018.09.002_bb0065","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.89.5.660","article-title":"The development of a formalin-killed Rift Valley fever virus vaccine for use in man","volume":"89","author":"Randall","year":"1962","journal-title":"J. Immunol."},{"issue":"27","key":"10.1016\/j.intimp.2018.09.002_bb0070","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1016\/j.vaccine.2010.04.048","article-title":"Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector","volume":"28","author":"Kortekaas","year":"2010","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.intimp.2018.09.002_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002309","article-title":"A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection","volume":"7","author":"Lopez-Gil","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"23","key":"10.1016\/j.intimp.2018.09.002_bb0080","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/j.vaccine.2012.03.027","article-title":"Efficacy of three candidate Rift Valley fever vaccines in sheep","volume":"30","author":"Kortekaas","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.intimp.2018.09.002_bb0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0042-6822(86)90114-5","article-title":"Messenger RNA of the M segment RNA of Rift Valley fever virus","volume":"151","author":"Collett","year":"1986","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.intimp.2018.09.002_bb0090","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0042-6822(91)90087-R","article-title":"Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses","volume":"180","author":"Giorgi","year":"1991","journal-title":"Virology"},{"issue":"Pt 6","key":"10.1016\/j.intimp.2018.09.002_bb0095","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1099\/0022-1317-75-6-1345","article-title":"Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases","volume":"75","author":"Muller","year":"1994","journal-title":"J. Gen. Virol."},{"issue":"11","key":"10.1016\/j.intimp.2018.09.002_bb0100","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1128\/CVI.00182-09","article-title":"A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity","volume":"16","author":"Holman","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2018.09.002_bb0105","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1128\/JVI.02483-08","article-title":"Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers","volume":"83","author":"Huiskonen","year":"2009","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.intimp.2018.09.002_bb0110","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.virol.2006.08.002","article-title":"Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins","volume":"357","author":"Gerrard","year":"2007","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.intimp.2018.09.002_bb0115","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15017772","article-title":"Development and characterization of Rift Valley fever virus-like particles","volume":"15","author":"Li","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.intimp.2018.09.002_bb0120","doi-asserted-by":"crossref","first-page":"24179","DOI":"10.1038\/srep24179","article-title":"Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection","volume":"6","author":"Zheng","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.intimp.2018.09.002_bb0125","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.12.19160-en","article-title":"International network for capacity building for the control of emerging viral vector-borne zoonotic diseases: ARBO-ZOONET","volume":"14","author":"Ahmed","year":"2009","journal-title":"Euro Surveill."},{"key":"10.1016\/j.intimp.2018.09.002_bb0130","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3389\/fmicb.2015.00676","article-title":"Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection","volume":"6","author":"Benedict","year":"2015","journal-title":"Front. Microbiol."},{"issue":"3\u20134","key":"10.1016\/j.intimp.2018.09.002_bb0135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.vetimm.2012.04.026","article-title":"Virus-like particles: the new frontier of vaccines for animal viral infections","volume":"148","author":"Crisci","year":"2012","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"2","key":"10.1016\/j.intimp.2018.09.002_bb0140","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4142\/jvs.2018.19.2.200","article-title":"Packaging of RVFV pseudoviruses and establishment of a neutralization assay method","volume":"19","author":"Li","year":"2018","journal-title":"J. Vet. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2018.09.002_bb0145","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0002-9343(80)90469-6","article-title":"Hypersensitivity reactions associated with botulinal antitoxin","volume":"69","author":"Black","year":"1980","journal-title":"Am. J. Med."},{"issue":"12","key":"10.1016\/j.intimp.2018.09.002_bb0150","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1745-7254.2005.00210.x","article-title":"Preparation and development of equine hyperimmune globulin F(ab\u2032)2 against severe acute respiratory syndrome coronavirus","volume":"26","author":"Lu","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.intimp.2018.09.002_bb0155","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.intimp.2006.10.009","article-title":"Inhibition of infection caused by severe acute respiratory syndrome-associated coronavirus by equine neutralizing antibody in aged mice","volume":"7","author":"Zhou","year":"2007","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2018.09.002_bb0160","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.intimp.2011.08.011","article-title":"Cross clade prophylactic and therapeutic efficacy of polyvalent equine immunoglobulin F(ab\u2032)2 against highly pathogenic avian influenza H5N1 in mice","volume":"11","author":"Zhao","year":"2011","journal-title":"Int. Immunopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918305368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918305368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T23:26:19Z","timestamp":1693869979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918305368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":32,"alternative-id":["S1567576918305368"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.09.002","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Equine immunoglobulin F(ab\u2032)2 fragments protect mice from Rift Valley fever virus infection","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}